Antiarrhythmic vs. pro-arrhythmic effects depending on the intensity of adrenergic stimulation in a canine anthopleurin-A model of type-3 long QT syndrome

Europace

Volumn 10, Issue 2, 2008, Pages 249-255

  Chinushi, Masaomi ^a   Izumi, Daisuke ^a   Iijima, Kenichi ^a   Ahara, Shizue ^a   Komura, Satoru ^a   Furushima, Hiroshi ^a   Hosaka, Yukio ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Adrenergic activity; Beta adrenergic blockade; Type 3 long QT syndrome

Indexed keywords

ADRENALIN; ANTHOPLEURIN A; PROPRANOLOL; ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTHOPLEURIN-A; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PEPTIDE; UNCLASSIFIED DRUG;

ADRENERGIC ACTIVITY; ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATRIOVENTRICULAR BLOCK; BETA ADRENERGIC RECEPTOR BLOCKING; DOG; ELECTROCARDIOGRAM; ELECTRODE; HEART LEFT VENTRICLE; HEART PACING; HEART REPOLARIZATION; HEART RIGHT VENTRICLE; HEART VENTRICLE REPOLARIZATION; LONG QT SYNDROME; NONHUMAN; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; ANIMAL; DISEASE MODEL; DRUG EFFECT; HEART VENTRICLE FUNCTION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENERGIC AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; DISEASE MODELS, ANIMAL; DOGS; EPINEPHRINE; LONG QT SYNDROME; PEPTIDES; PROPRANOLOL; RECEPTORS, ADRENERGIC; VENTRICULAR FUNCTION;

EID: 41949126845     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun002     Document Type: Article

References (33)

1. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C et al. Genotype-phenotype correlation in the long QT syndrome. Gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103:89-95.
2. Roden DM, Lazzara R, Rosen MR, Schwartz PJ, Towbin J, Vincent GM. Multiple mechanisms in the long QT syndrome: current knowledge, gaps and future directions. Circulation 1996;94:1996-2012.
3. Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. Circulation 1991;84:503-11.
4. Moss AJ, Zareba W, Hall J, Schwartz PJ, Crampton RS, Benhorin J et al. Effectiveness and limitations of β-blocker therapy in congenital long QT syndrome. Circulation 2000;101:616-23.
5. Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E et al. Association of long QT syndrome loci and cardiac events among patients treated with b-blockers. JAMA 2004;292:1341-4.
6. Shimizu W, Antzelevitch C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 2000;35:778-86.
7. + channel blockade, beta-adrenergic stimulation and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long QT syndrome. Circ Res 1996;98:2314-22.
8. Shimizu W, Antzelevitch C. Cellular basis for the electrocardiographic features of the LQT1 form of the long QT syndrome: effects of β-adrenergic agonists, antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 1998;98:2314- 22.
9. Head CE, Balasubramaniam R, Thomas G, Goddard CA, Lei M, Colledge WH et al. Paced electrogram fractionation analysis of arrhythmogenic tendency in ΔKPQ Scn5a Mice. J Cardiovasc Electrophysiol 2005;16:1329-40.
10. Nuyens D, Stengl M, Dugarmaa S, Rossenbacker T, Compernolle V, Rudy Y et al. Abrupt rate acceleration or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med 2001;7:1021- 7.
11. El-Sherif N, Caref EB, Chinushi M, Restivo M. Mechanism of arrhythmogenicity of the short-long cardiac sequence that precedes ventricular tachyarrhythmias in the long QT syndrome. J Am Coll Cardiol 1999;33:1415-23.
12. Chinushi M, Hosaka Y, Washizuka T, Furushima H, Aizawa Y. Arrhythmogenesis of T wave alternans associated with surface QRS complex alternans and the role of ventricular prematurity (Observations from a canine model of LQT3 syndrome). J Cardiovasc Electrophysiol 2002;13:599- 604.
13. Chinushi M, Caref EB, Restivo M, Noll G, Aizawa Y, El-Sherif N. Cyclelength associated modulation of the regional dispersion of ventricular repolarization in a canine model of long QT syndrome. Pacing Clin Electrophysiol 2001;24:1247-57.
14. Sicouri S, Fish J, Antzelevitch C. Distribution of M cells in the canine ventricle. J Cardiovasc Electrophysiol 1994;5:824-37.
15. Millar CK, Kralios FA, Lux RL. Correlation between refractory periods and ARIs from electrograms: effects of rate and adrenergic interventions. Circulation 1985;72:1372-9.
16. Haws CW, Lux RL. Correlation between in vivo transmembrane action potential durations and activation recovery intervals from electrograms: effects of interventions that alter repolarization time. Circulation 1991;81:281-28.
17. El-Sherif N, Caref EB, Yin H, Restivo M. The electrophysiological mechanism of ventricular tachyarrhythmias in the long QT syndrome: three-dimensional mapping of activation and recovery patterns. Circ Res 1996;79:474-92.
18. El-Sherif N, Chinushi M, Caref EB, Restivo M. Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long QT syndrome. Circulation 1997;96:4392-9.
19. Chinushi M, Restivo M, Caref EB, El-Sherif N. The electrophysiological basis of arrhythmogenecity of QT/T alternans in long QT syndrome. Tridimentional analysis of the kinetics of cardiac repolarization. Circ Res 1998;83:614-28.
20. Zygmunt AC. Intracellular calcium activates chloride current in canine ventricular myocytes. Am J Physiol 1994;267:H1984-95.
21. Zygmunt AC, Goodrow RJ, Antzelevitch C. INaCa contributes to electrical heterogeneity within the canine ventricle. Am J Physiol Heart Circ Physiol 2000;278:H1671-67.
22. Liu DW, Antzelevitch C. Characteristics of the delayed rectifier current (Ikr and Iks) in canine ventricular epicardial, midmyocardial, and endocardial myocytes: a weaker Iks contributes to the longer action potential of the M cell. Circ Res 1995;76:351-65.
23. Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 2004;1:276-83.
24. Zygmunt AC, Eddlestone GT, Thomas GP, Nesterenko VV, Antzelevitch C. Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. Am J Physiol Heart Circ Physiol 2001;281:H689-97.
25. Yan GX, Shimizu W, Antzelevitch C. Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations. Circulation 1998;98:1921-7.
26. Restiovo M, Caref EB, Kozhevnikov DO, El-Sherif N. Spatial dispersion of repolarization is a key factor in the arrhythmogenicity of long QT syndrome. J Cardiovasc Electrophysiol 2004;15:323-31.
27. Surawicz B. Electrophysiological substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations? J Am Coll Cardiol 1989;14:172-84.
28. Shimizu W, Aiba T, Antzelevitch C. Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome. Curr Pharm Des 2005;11:1561-72.
29. Viskin S, Rosso R, Rogowski O, Belhassen B, Levitas A, Wagshal A et al. Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT response in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome. Eur Heart J 2006;27:469-75.
30. Boyett MR, Jewell BR. A study of the factors responsible for ratedependent shortening of the action potential in mammalian ventricular muscle. J Physiol (Lond) 1978;285:359-80.
31. Riccio ML, Koller ML, Gilmour RF Jr. Electrical restitution and spatiotemporal organization during ventricular fibrillation. Circ Res 1999;84:955-63.
32. Yamauchi S, Yamaki M, Watanabe T, Yuuki K, Kubota I, Tomoike H. Restitution properties and occurrence of ventricular arrhythmia in LQT2 type of Long QT syndrome. J Cardiovasc Electrophysiol 2002;13:910-4.
33. Sabir IN, Li LM, Jones VJ, Goddard CA, Grace AA, Huang C L-H. Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modeling the congenital long QT syndrome type 3 and the Brugada syndrome. Pflugers Arch 2008;455:637-51. Epub September 6, 2007.